Timely antiviral therapy may slow COVID-19 progression; more study needed

Researchers in China found that hospitalized patients with milder cases of COVID-19 were treated earlier with an assortment of antivirals compared with patients who experienced more severe disease, suggesting that the timing of antiviral therapy may significantly slow COVID-19 progression.However, the study was underpowered to evaluate the therapeutic effect of the drugs, which included ribavirin, lopinavir and ritonavir.“The guideline for diagnosis and treatment of COVID-19 issued by WHO and National Health Commission of the People’s Republic of China suggests that ribavirin,Read More

Share on facebook
Share on twitter
Share on linkedin